Clinical Utility of Resistin as a New Marker of Acute Coronary Syndrome

Mohamad Mahmoud Ahmad Awad;

Abstract


The present study included 80 subjects; 60 patients with ACS and 20 controls. Patients were classified into GΙa (stable angina SA, n=20),GΙb (unstable angina UA, n=20) and GΙc (myocardial infarction MI, n=20) according to clinical picture, ECG an


Other data

Title Clinical Utility of Resistin as a New Marker of Acute Coronary Syndrome
Other Titles الأستخدام الأكلينيكى للريزستين كدلالة جديدة لمتلازمة الشرايين التاجية
Authors Mohamad Mahmoud Ahmad Awad
Keywords Clinical Utility of Resistin as a New Marker of Acute Coronary Syndrome
Issue Date 2011
Description 
The present study included 80 subjects; 60 patients with ACS and 20 controls. Patients were classified into GΙa (stable angina SA, n=20),GΙb (unstable angina UA, n=20) and GΙc (myocardial infarction MI, n=20) according to clinical picture, ECG an

Attached Files

File SizeFormat
106833p4204.pdf762.45 kBAdobe PDFView/Open
Recommend this item

Similar Items from Core Recommender Database

Google ScholarTM

Check

views 3 in Shams Scholar


Items in Ain Shams Scholar are protected by copyright, with all rights reserved, unless otherwise indicated.